These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25903932)

  • 1. Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation.
    Marcelletti JF; Evans CL; Saxena M; Lopez AE
    AAPS J; 2015 Jul; 17(4):939-47. PubMed ID: 25903932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment.
    Kelley M; Stevenson L; Golob M; Devanarayan V; Pedras-Vasconcelos J; Staack RF; Jenkins R; Booth B; Wakshull E; Bowsher R; Rock M; Dudal S; DeSilva B
    AAPS J; 2015 Jul; 17(4):1019-24. PubMed ID: 25921938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons.
    Tu J; Bennett P
    Bioanalysis; 2017 Jul; 9(14):1107-1122. PubMed ID: 28737442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance of a commercial multiplex Luminex-based cytokine panel in the rat.
    Erkens T; Goeminne N; Kegels A; Byloos M; Vinken P
    J Pharmacol Toxicol Methods; 2018; 91():43-49. PubMed ID: 29371052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of fit-for-purpose biomarker validations: an LBA perspective.
    Neely RJ
    Bioanalysis; 2018 Jun; 10(12):905-907. PubMed ID: 29923756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When close is not close enough: a comparison of endogenous and recombinant biomarker stability samples.
    Fraser S; Fleener C; Ogborne K; Soderstrom C
    Bioanalysis; 2015; 7(11):1355-60. PubMed ID: 26110708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical biomarker validation.
    Allinson JL
    Bioanalysis; 2018 Jun; 10(12):957-968. PubMed ID: 29923754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.
    Yeung D; Ciotti S; Purushothama S; Gharakhani E; Kuesters G; Schlain B; Shen C; Donaldson D; Mikulskis A
    J Immunol Methods; 2016 Oct; 437():53-63. PubMed ID: 27555238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalytical qualification of clinical biomarker assays in plasma using a novel multi-analyte Simple Plex
    Gupta V; Davancaze T; Good J; Kalia N; Anderson M; Wallin JJ; Brady A; Song A; Xu W
    Bioanalysis; 2016 Dec; 8(23):2415-2428. PubMed ID: 27855508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological and analytic considerations for blood biomarkers.
    Christenson RH; Duh SH
    Prog Cardiovasc Dis; 2012; 55(1):25-33. PubMed ID: 22824107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding new "exploratory" biomarker data: a first look at observed concentrations and associated detection limits.
    Pleil JD
    Biomarkers; 2015 Mar; 20(2):168-9. PubMed ID: 25980452
    [No Abstract]   [Full Text] [Related]  

  • 14. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.
    Lee JW; Hall M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.
    Jani D; Allinson J; Berisha F; Cowan KJ; Devanarayan V; Gleason C; Jeromin A; Keller S; Khan MU; Nowatzke B; Rhyne P; Stephen L
    AAPS J; 2016 Jan; 18(1):1-14. PubMed ID: 26377333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
    Lee JW
    Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.
    Bower J; Fast D; Garofolo F; Gouty D; Hayes R; Lowes S; Nicholson R; LeLacheur R; Bravo J; Shoup R; Dumont I; Carbone M; Zimmer J; Ortuno J; Caturla MC; Datin J; Lansing T; Fatmi S; Struwe P; Sheldon C; Islam R; Yu M; Hulse J; Kamerud J; Lin J; Doughty J; Kurylak K; Tang D; Buonarati M; Blanchette A; Levesque A; Gagnon-Carignan S; Lin J; Ray G; Liu Y; Khan M; Xu A; El-Sulayman G; DiMarco C; Bouhajib M; Tacey D; Jenkins R; der Strate Bv; Briscoe C; Karnik S; Rhyne P; Garofolo W; Schultz G; Roberts A; Redrup M; DuBey I; Conliffe P; Pekol T; Hantash J; Cojocaru L; Allen M; Reuschel S; Watson A; Farrell C; Groeber E; Malone M; Nowatzke W; Fang X
    Bioanalysis; 2014; 6(22):2957-63. PubMed ID: 25496252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.
    Islam R; Briscoe C; Bower J; Cape S; Arnold M; Hayes R; Warren M; Karnik S; Stouffer B; Xiao YQ; van der Strate B; Sikkema D; Fang X; Tudoroniu A; Tayyem R; Brant A; Spriggs F; Barry C; Khan M; Keyhani A; Zimmer J; Caturla MC; Couerbe P; Khadang A; Bourdage J; Datin J; Zemo J; Hughes N; Fatmi S; Sheldon C; Fountain S; Satterwhite C; Colletti K; Vija J; Yu M; Stamatopoulos J; Lin J; Wilfahrt J; Dinan A; Ohorodnik S; Hulse J; Patel V; Garofolo W; Savoie N; Brown M; Papac D; Buonarati M; Hristopoulos G; Beaver C; Boudreau N; Williard C; Liu Y; Ray G; Warrino D; Xu A; Green R; Hayward-Sewell J; Marcelletti J; Sanchez C; Kennedy M; Charles JS; Bouhajib M; Nehls C; Tabler E; Tu J; Joyce P; Iordachescu A; DuBey I; Lindsay J; Yamashita J; Wells E
    Bioanalysis; 2018 Apr; 10(7):433-444. PubMed ID: 29701066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.
    DeSilva B; Smith W; Weiner R; Kelley M; Smolec J; Lee B; Khan M; Tacey R; Hill H; Celniker A
    Pharm Res; 2003 Nov; 20(11):1885-900. PubMed ID: 14661937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Practices and Challenges in Method Validation.
    Poitout F; Colangelo JL; Lavallée S; Aulbach AD; Piché MS; Ennulat D; Ameri M; Boone LI
    Toxicol Pathol; 2018 Oct; 46(7):847-856. PubMed ID: 30253718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.